Inventor · disambiguated record
Yan Chen
Also filed as: CHEN YAN · CHEN YAN-YING
86 granted patents·24 pending applications·813 citations·filing 1998–2025
99Inventor score
Files withRIGEL PHARMACEUTICALS INC63THERAVANCE INC13THERAVANCE RESPIRATORY CO LLC9LI HUI4BRISTOL MYERS SQUIBB CO3
Top patents by PatentIndex Score
110 records- 0197US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 0297US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 0396US10590121B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·10 cites·37 claims
- 0496US7524959B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 28, 2009·36 cites·19 claims
- 0596US7521561B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 21, 2009·36 cites·19 claims
- 0696US7514558B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 7, 2009·32 cites·18 claims
- 0796US7355046B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 8, 2008·42 cites·17 claims
- 0896US7345175B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Mar 18, 2008·49 cites·17 claims
- 0996US7141671B2Biphenyl derivativesTHERAVANCE INC·Filed 2004·Granted Nov 28, 2006·145 cites·42 claims
- 1095US9982000B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·16 cites·14 claims
- 1195US8735400B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted May 27, 2014·21 cites·24 claims
- 1295US8324200B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Dec 4, 2012·23 cites·46 claims
- 1395US7507751B2Biphenyl derivativesTHERAVANCE INC·Filed 2007·Granted Mar 24, 2009·33 cites·21 claims
- 1494US11370787B2Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·4 cites·23 claims
- 1594US7879879B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Feb 1, 2011·19 cites·7 claims
- 1693US7829583B2Biphenyl derivativesTHERAVANCE INC·Filed 2007·Granted Nov 9, 2010·15 cites·21 claims
- 1792US10663105B2Supporting deviceSYNCMOLD ENTPR CORP·Filed 2019·Granted May 26, 2020·15 cites·13 claims
- 1892US9067925B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Jun 30, 2015·11 cites·10 claims
- 1991US9682957B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Jun 20, 2017·5 cites·2 claims
- 2091US9572802B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Feb 21, 2017·5 cites·30 claims
- 2191US9000173B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2014·Granted Apr 7, 2015·7 cites·5 claims
- 2291US8816088B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE INC·Filed 2013·Granted Aug 26, 2014·7 cites·1 claims
- 2391US8138345B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM·Filed 2010·Granted Mar 20, 2012·13 cites·3 claims
- 2490US10774076B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Sep 15, 2020·3 cites·21 claims
- 2590US10208074B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·5 cites·11 claims
- 2690US9975875B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted May 22, 2018·4 cites·3 claims
- 2790US8551978B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2012·Granted Oct 8, 2013·7 cites·6 claims
- 2889US10208075B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·4 cites·17 claims
- 2989US9771350B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted Sep 26, 2017·4 cites·2 claims
- 3089US8343954B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·8 cites·7 claims
- 3189US2025326778A1Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3288US11919890B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·1 cites·18 claims
- 3388US11530194B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·24 claims
- 3488US11492349B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 8, 2022·1 cites·21 claims
- 3588US9611260B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Apr 4, 2017·4 cites·14 claims
- 3688US9566278B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·6 cites·21 claims
- 3787US9566283B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·3 cites·12 claims
- 3887US9248132B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·1 claims
- 3987US9084795B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·4 cites·19 claims
- 4087US8969571B2Biphenyl derivativesMAMMEN MATHAI·Filed 2013·Granted Mar 3, 2015·5 cites·3 claims
- 4187US6124269A2-Halo-6-O-substituted ketolide derivativesABBOTT LAB·Filed 1998·Granted Sep 26, 2000·97 cites·14 claims
- 4287US2024368119A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4386US11299486B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·1 cites·11 claims
- 4486US10065946B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Sep 4, 2018·4 cites·24 claims
- 4586US6420535B16-O-carbamate ketolide derivativesABBOTT LAB·Filed 2000·Granted Jul 16, 2002·35 cites·14 claims
- 4685US9321763B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Apr 26, 2016·6 cites·64 claims
- 4785US7250414B2Diphenylmethyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Jul 31, 2007·7 cites·25 claims
- 4884US10479783B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Nov 19, 2019·2 cites·6 claims
- 4983US11059814B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jul 13, 2021·1 cites·15 claims
- 5083US10947216B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·1 cites·28 claims
Showing the top 50 of 110 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yan Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →